MOREPENLAB
Invest Now
Morepen Laboratories Share Price
₹86.40 +0.03 (0.03%)
06 Dec, 2024 12:17
Start SIP in MOREPENLAB
Start SIPPerformance
- Low
- ₹86
- High
- ₹88
- 52 Week Low
- ₹39
- 52 Week High
- ₹101
- Open Price₹87
- Previous Close₹86
- Volume3,439,093
Investment Returns
- Over 1 Month + 4.93%
- Over 3 Month -7.55%
- Over 6 Month + 92.64%
- Over 1 Year + 97.26%
Smart Investing Starts Here Start SIP with Morepen Laboratories for Steady Growth!
Morepen Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 36.1
- PEG Ratio
- 0.2
- Market Cap Cr
- 4,734
- P/B Ratio
- 5.6
- Average True Range
- 3.53
- EPS
- 2.4
- Dividend Yield
- 0
- MACD Signal
- -0.57
- RSI
- 63.77
- MFI
- 85.67
Morepen Laboratories Financials
Morepen Laboratories Technicals
EMA & SMA
Current Price
₹86.40
+
0.03
(0.03%)
- Bullish Moving Average 16
- Bearish Moving Average 0
- 20 Day
- ₹80.52
- 50 Day
- ₹80.02
- 100 Day
- ₹75.70
- 200 Day
- ₹66.73
Resistance and Support
86.94
- R3 90.33
- R2 89.39
- R1 87.88
- S1 85.43
- S2 84.49
- S3 82.98
Morepen Laboratories Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-21 | Audited Results | |
2024-01-31 | Quarterly Results | |
2023-11-02 | Quarterly Results |
Morepen Laboratories F&O
About Morepen Laboratories
- NSE Symbol
- MOREPENLAB
- BSE Symbol
- 500288
- Chairman & Managing Director
- Mr. Sushil Suri
- ISIN
- INE083A01026
Similar Stocks to Morepen Laboratories
Morepen Laboratories FAQs
Morepen Laboratories share price is ₹86 As on 06 December, 2024 | 12:03
The Market Cap of Morepen Laboratories is ₹4734.3 Cr As on 06 December, 2024 | 12:03
The P/E ratio of Morepen Laboratories is 36.1 As on 06 December, 2024 | 12:03
The PB ratio of Morepen Laboratories is 5.6 As on 06 December, 2024 | 12:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.